June Sherie Almenoff - 17 Nov 2025 Form 4/A - Amendment Insider Report for TENAX THERAPEUTICS, INC. (TENX)

Role
Director
Signature
/s/ S. Halle Vakani, as Attorney-in-Fact
Issuer symbol
TENX
Transactions as of
17 Nov 2025
Transactions value $
$14,945
Form type
4/A - Amendment
Filing time
20 Nov 2025, 18:16:44 UTC
Date Of Original Report
19 Nov 2025
Previous filing
03 Jul 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Almenoff June Sherie Director 101 GLEN LENNOX DRIVE, SUITE 300, CHAPEL HILL /s/ S. Halle Vakani, as Attorney-in-Fact 20 Nov 2025 0001492647

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TENX Common Stock Purchase $665 +93 $7.15 93 17 Nov 2025 By Meadowlark Management, LLC F1
transaction TENX Common Stock Purchase $14.3K +1.9K +2043.01% $7.52 1.99K 18 Nov 2025 By Meadowlark Management, LLC F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reporting person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein.
F2 This transaction was executed in multiple trades at prices ranging from $7.45 to $7.70. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

Remarks:

This amendment is being filed to correct the ownership form of the 1,993 shares acquired, which was inadvertently reported on the original filing as direct. Columns 6 and 7 have been adjusted to reflect this correction.